Compass Course: Efficacy Study
1 other identifier
interventional
41
1 country
3
Brief Summary
The Compass Course is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervention is to provide participants with information, tools, and support that help them move towards reclaiming a sense of self-grounded purpose in daily life. The study will use a convenience sample of breast cancer survivors to evaluate the efficacy of the Compass Course intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Mar 2018
Typical duration for not_applicable breast-cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
March 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedMay 12, 2021
May 1, 2021
3.2 years
February 16, 2018
May 10, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in psychological well-being
Using the Psychological Scales of Wellbeing questionnaire (Ryff, 1989; Ryff, \& Keyes, 1995), psychological wellbeing pre- and post- intervention will be tracked.
Will be administered at Week 0 (pre-testing), at Week 12 (session 8), and at 3 month follow up
Secondary Outcomes (10)
Recruitment
Up to 1 month after IRB approval
Time of pre-testing session
Duration of pre-testing session (approximately 2 hours) at week 0 to week 1
Time of testing session
Each week from week 2 through week 8, approximately 2 hours at each session
Time of post-testing session
Duration of session 8 (at week 12), approximately 1 hour
Homework completion
Each week from week 2 through week 8
- +5 more secondary outcomes
Study Arms (2)
Spring 2018 Compass Course Group
EXPERIMENTALTwo groups of up to 15 participants (30 total) will receive the study intervention during Spring 2018. All participants will complete study questionnaires before and after the Spring sessions.
Spring 2018 Comparison Group
NO INTERVENTIONTwo groups of up to 15 participants will receive the study intervention in Fall 2018. All participants will complete study questionnaires before and after the Spring sessions. Those who enroll in the study and agree to participate in the Fall sessions will serve as a no-treatment comparison group.
Interventions
An 8-session group intervention that integrates education, support, self-reflection, and action-expectation to help people reaffirm or reconstruct self-grounded purpose after significant life events/transitions. The 8 sessions extend over 2-3 months, with 7 weekly sessions and the final session 1 month after Session 7. The intervention, called the Compass Course is structured around the 6 dimensions of flourishing (autonomy, self-acceptance, personal growth, relationships, purpose in life, external mastery), the goal of which is to help people enact behaviors that move them forward in reframing a sense of self and reaffirming or reconstructing a sense of purpose in their daily lives.
Eligibility Criteria
You may qualify if:
- years of age or older
- Completed treatment (such as chemotherapy, radiation, surgery) for Stage 0, 1, 2, or 3 breast cancer at least 2 months prior to participating in the Compass Course intervention
- English speaking
- High school diploma or GED
- Able to see, hear, speak (with or without assistive devices)
- Able to provide own transportation to sessions
- Willing and able to commit to attend all 8 intervention sessions
You may not qualify if:
- Stage 4 breast cancer or any other stage 4 cancer
- Actively receiving chemotherapy or radiation treatments for cancer. (However, patients may be on Herceptin and/or endocrine treatment and participate in the study.)
- History of neurologic disorder (such as stroke or brain injury) with residual impairments that likely interfere with learning
- Any medical condition (physical or mental health) that interferes with the performance of everyday activities and roles.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Courage Kenny Rehabilitation Institute
Golden Valley, Minnesota, 55422, United States
Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
Allina Health Shoreview Clinic
Shoreview, Minnesota, 55126, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Radomski, PhD, OTR/L
Allina Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientific Advisor
Study Record Dates
First Submitted
February 16, 2018
First Posted
February 22, 2018
Study Start
March 2, 2018
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
May 12, 2021
Record last verified: 2021-05